Lipidomic profiling reveals medium-chain acylcarnitines alterations as metabolic signatures in IgA nephropathy
Abstract Immunoglobulin A nephropathy (IgAN), the most common primary glomerulonephritis worldwide, exhibits highly variable clinical progression, ranging from asymptomatic urinary abnormalities with potential for spontaneous resolution to progressive kidney failure over 10–20 years. The limited und...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2026-02-01
|
| Seri Bilgileri: | BMC Nephrology |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12882-026-04822-3 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|